2'3'-cyclic dinucleotides and prodrugs thereof
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F23%3A00579267" target="_blank" >RIV/61388963:_____/23:00579267 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/069845482/publication/CA3129022C?q=CA3129022C" target="_blank" >https://worldwide.espacenet.com/patent/search/family/069845482/publication/CA3129022C?q=CA3129022C</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
2'3'-cyclic dinucleotides and prodrugs thereof
Original language description
The present disclosure relates to 2'3' cyclic phosphonate dinucleotides of Formula (I), their pharmaceutically acceptable salts, their pharmaceutical composition and combinations of said substances and other medicaments or pharmaceuticals. The disclosure also relates to the use of said compounds for the treatment or prevention of diseases or conditions modifiable by STING protein modulation, such as cancer or viral, allergic and inflammatory diseases. In addition, these substances can be used as adjuvants in vaccines.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
<a href="/en/project/EF16_019%2F0000729" target="_blank" >EF16_019/0000729: Chemical biology for drugging undruggable targets</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
CA3129022
Publisher
CA001 -
Publisher name
Canadian Intellectual Property Office (CIPO)
Place of publication
Gatineau, Québec
Publication country
CA - CANADA
Date of acceptance
Aug 1, 2023
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence